RM
Ram Mukunda
CEODirector

Ram Mukunda insider trades: IGC Pharma (IGC) stock sales

CEO, IGC Pharma Last trade Mar 2, 2021 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2017
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ram reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 2, 2021IGC↓ Sell$107K
Nov 30, 2020IGC↓ Sell$187K
Aug 30, 2018IGC↓ Sell$93K
Aug 28, 2018IGC↓ Sell$166K
Aug 24, 2018IGC↓ Sell$41K
Jan 12, 2018IGC↓ Sell$39K
Dec 15, 2017IGC↓ Sell$38K
Dec 8, 2017IGC↓ Sell$133K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ram Mukunda's insider trades

Ram Mukunda is CEO at IGC Pharma (IGC). Since Dec 8, 2017, Ram has reported no open-market purchases and 8 sales worth $804K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (16 filings), gifts (6 filings), option exercises (5 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IGC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.